This industry-sponsored symposium, held at ESMO 2024, is a medical education activity that is organised and funded by the medical department of Bristol Myers Squibb.
Description
At the European Society for Medical Oncology (ESMO) 2024, renowned experts, Michael Jewett, Andrea Necchi and Laurence Albiges discuss the clinical experience and the current landscape in bladder and kidney cancers. Exploring the role of long-term efficacy and safety outcomes, assessment of quality of life, and different routes of administration on shared decision making in bladder and kidney cancers. Also to improve the understanding of the importance of patient voice and engagement in bladder and kidney cancer management including the role of shared decision making
Speakers
Michael Jewett, MD, PhD, FRCSC, FACS, CM1
Andrea Necchi, MD2
Laurence Albiges, MD, PhD3
1. Board Chair, International Kidney Cancer Coalition Departments of Surgery (Urology) and Surgical Oncology Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Canada
2. Associate Professor, Vita-Salute San Raffaele University Head of Genitourinary Medical Oncology, IRCCS San Raffaele Hospital Milan, Italy
3. Professor of Medical Oncology, Paris Saclay University Chair, Medical Oncology Department Gustave Roussy Cancer Center Villejuif, France
